Select Page

Market Research Future adds the “Eye cancer Market Research Report – Forecast to 2023” report to their unique collection.

Market Scenario:

Eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably leading to the formation of tumors. Different types of eye cancers are observed namely intraocular cancer, squamous cell cancer, rhabdomyosarcoma, and others. These types of cancer affects eyeball, orbit (eye socket), and adnexal (accessory) structures. Over 100 types of cancers have been identified. According to cancer research UK, in 2012, globally over 14.1 million of new cancer cases were registered, which is expected to increase continuously in coming future. Additionally, as per the report published in American Society of Clinical Oncology, in 2015, over 3500 patients in the US were diagnosed with primary intraocular cancer. Because of deteriorating lifestyle due to alcoholism and smoking, there is a continued rise in the incidence of cancer. The global eye cancer market is majorly driven by the increasing prevalence of eye cancer across the globe. Additionally, increasing government support for research & development, rising healthcare expenditure and changing lifestyle has fuelled the market growth. Many types of treatment are available in the market, however, all the treatment show some or other side effects on the body. Side effects of the treatment, and high cost of the medicines may slow the growth of the market during the forecasted period.

Also Read : https://www.medgadget.com/2018/06/eye-cancer-market-is-expected-to-generate-huge-profits-top-vendors-treatment-diagnosis-and-cagr-of-8-3-during-forecast-period-2017-to-2023.html 

The global eye cancer market is expected to grow at a CAGR of ~8.3 % during the forecast period 2017-2023.

Intended Audience

  • Pharmaceutical Companies
  • Government and private research companies
  • Research and Development (R&D) Companies
  • Drug Manufacturers and Suppliers
  • Medical Research Laboratories 

Segmentation

The global eye cancer market is segmented on the basis of types, treatment and end users.

On the basis of types, the market is segmented into intraocular cancer, squamous cell cancer, rhabdomyosarcoma, and others. Intraocular cancer is further segmented into melanoma of the eye, lymphoma of the eye, and eye cancers in children.

On the basis of treatment, the market is categorised into chemotherapy, surgery & radiation therapy, targeted therapy, hormone therapy, biologic therapy, and other. Chemotherapy is further segmented into anthracyclines, taxanes, antimetabolites, and alkylating agents. Target therapy is sub segmented into monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others.

On the basis of end users, the market is segmented into hospital & clinics, ambulatory care centers and others.

Key Players for Global Eye Cancer Market

Some of key the players in the market are Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), GlaxoSmithKline Plc. (U.K.),Bayer AG (Germany), Amgen, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.),  Sanofi (France), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Oncomed Pharmaceuticals (U.S.) and Immunomedics (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eye-cancer-market-4736